Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$467M |
| 2 |
Centene
CNC
|
+$104M |
| 3 |
Global Payments
GPN
|
+$80.4M |
| 4 |
WCC
WESCO International
WCC
|
+$65M |
| 5 |
Avis
CAR
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$200M |
| 2 |
Universal Health Services
UHS
|
+$154M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$113M |
| 4 |
Corteva
CTVA
|
+$94.4M |
| 5 |
DXC Technology
DXC
|
+$76.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.66% |
| 2 | Technology | 14.48% |
| 3 | Industrials | 10.25% |
| 4 | Materials | 8.76% |
| 5 | Consumer Discretionary | 3.84% |
Similar funds
Glenview Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Glenview Capital Management held 54 positions worth $5.08B, down 11% from $5.72B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Glenview Capital Management withdrew a net $357M in Q2 2024, closing 6 positions and reducing 20 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $53.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.
Against the trend, Glenview Capital Management opened a new position in Centene worth $94.9M.
- Glenview Capital Management's largest Q2 2024 buy was Centene: 1,431,312 shares worth $94.9M.
- Glenview Capital Management added most to CVS Health in Q2 2024, an estimated $467M increase.
- Glenview Capital Management's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $200M.
- Glenview Capital Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $53.1M.
- Glenview Capital Management's ten largest holdings make up 63% of its $5.08B portfolio in Q2 2024.
- Glenview Capital Management opened 9 new positions and closed 6 in Q2 2024.
- Glenview Capital Management's portfolio value fell 11% quarter-over-quarter to $5.08B.
Based on Glenview Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.